TORIGEN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 29 Jan 2025)
What this means for you
Registered since 15 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87111062
- Registration number
- 5656200
- Mark type
- Stylized text
- Filed
- 20 Jul 2016
- Published for opposition
- 24 Apr 2018
- Registered
- 15 Jan 2019
- Attorney of record
- Denise Mayfield
Goods and services
- Class 042 — Scientific and technological services: Biotechnology research; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development in the pharmaceutical and biotechnology fields
Owner
- Torigen Pharmaceuticals, Inc., Vernon, CT, US
- Torigen Pharmaceuticals, Inc., Vernon, CT, US
- Torigen Pharmaceuticals, Inc., Vernon, CT, US
Prosecution history
- 29 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 29 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 15 Jan 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Mar 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Mar 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Mar 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 11 Dec 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Dec 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Nov 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Oct 2018 — USE AMENDMENT FILED
- 02 Nov 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Oct 2018 — TEAS STATEMENT OF USE RECEIVED